June 2026
The global pharmaceutical CDMO for formulations market size is accounted to hit around USD 103.33 billion by 2035, increasing from USD 52.56 billion in 2026, with a CAGR of 7.78%.
September 2026
Europe Pharmaceutical CDMO market size is projected to hit around USD 94.94 billion by 2035, rising from USD 49.06 billion in 2026, growing at a CAGR of 7.59%.
September 2026
The active pharmaceutical ingredients CDMO market reached USD 125.99 billion in 2026, with key active pharmaceutical ingredients CDMO market companies including Lonza, Thermo Fisher Scientific.
September 2026
The U.S. pharmaceutical CDMO market size was calculated at USD 46.55 billion in 2026 and is predicted to reach around USD 83.25 billion by 2034, with a CAGR of 7.47%.
September 2026
The global liquid filtration for pharmaceutical market is growing as demand rises for sterile drug manufacturing and contamination control.
March 2026
The global pharmaceutical CDMO market size is calculated at USD 197.40 billion in 2025 and is projected to hit around USD 392.67 billion by 2035 with a CAGR of 7.12%.
January 2026
The global radiopharmaceutical CDMO market size was evaluated at USD 3.24 billion in 2025 and is predicted to hit around USD 8.50 billion by 2035, growing at a CAGR of 10.12%.
September 2026
The global pharmaceutical CRO market size was evaluated at USD 51.44 billion in 2026 and is projected to attain around USD 91.20 billion by 2034, with a CAGR of 7.42%.
September 2026
The pharmaceutical Inspection Machines Market size totalled USD 1.30 billion in 2026, with major pharmaceutical Inspection Machines Market players including ACG Worldwide, Brevetti C.E.A. S.p.A.
September 2026
The global pharmaceutical excipients market size is evaluated at USD 9.86 billion in 2026 and is expected to surpass USD 16.14 billion by 2035, with a CAGR of 5.66%.
September 2026
The U.S. pharmaceutical market was valued at USD 552.72 billion in 2026, with leading companies including Johnson & Johnson, Pfizer, Merck & Co., AbbVie, Bristol Myers Squibb, Eli Lilly.
September 2026
The global bispecific antibodies CDMO market expands with demand for next-generation therapeutics, advanced expression systems, and regulatory compliance expertise.
September 2026
The global pharmaceutical filtration market size is calculated at USD 14.27 billion in 2026 and is projected to hit around USD 21.23 billion by 2035 with aCAGR of 4.52%.
September 2026
The global checkpoint inhibitor biologics CDMO market is growing as demand rises for outsourced biologics development and scalable immuno-oncology manufacturing.
September 2026
The global biotechnology and pharmaceutical services outsourcing market size is projected to hit around USD 90.28 billion by 2035 from USD 54.53 billion in 2026 with a CAGR of 5.77%.
September 2026
The global AI in pharmaceutical market size was valued at USD 2.51 billion in 2026 and is projected to hit USD 18.99 billion by 2035 with a CAGR of 27%.
September 2026
The global RFID in pharmaceuticals market size is expected to hit around USD 15.19 billion by 2034 from USD 8.35 billion in 2026 with a CAGR of 7.81%.
September 2026
The pharmaceutical cartridges market size was exhibited at USD 1.83 billion in 2026 and is expected to hit around USD 3.67 billion by 2035 with a CAGR of 8.06% from 2026 to 2035.
September 2026
The global pharmaceutical capsule filling machines market is growing as demand rises for efficient, high-speed production of oral solid dosage forms.
September 2026
The pharmaceutical contract manufacturing and research services market size is estimated to hit around USD 525.32 billion by 2035, increasing from USD 282.99 billion in 2026, with a CAGR of 7.11%.
September 2026
The global veterinary CRO and CDMO market size was valued at USD 8.38 billion in 2026 and is predicted to surpass around USD 17.15 billion by 2035 with a CAGR of 8.30%.
September 2026
The global cannabis pharmaceuticals market size is projected to surpass around USD 1,439.34 billion by 2035 from USD 24.34 billion in 2026 with a CAGR of 57.75%.
September 2026
The pharmaceutical intermediates market is valued at USD 38.90 billion in 2026 and is expected to hit around USD 59.70 billion by 2035, growing at a CAGR of 4.89% from 2026 to 2035.
September 2026
The global biopharmaceuticals market size was valued at USD 616.02 billion in 2026 and is projected to hit around USD 1,983.73 billion by 2035 with a CAGR of 13.95%.
September 2026
The global biopharmaceutical third party logistics market size was valued at USD 162.98 billion in 2026 and is expected to hit around USD 287.89 billion by 2035, growing at a CAGR of 6.53%
September 2026
The global artificial intelligence (AI) in biopharmaceutical market size is projected to hit around USD 29.78 billion by 2035 from USD 1.99 billion in 2025 with a CAGR of 31.07%.
September 2026
The global live biotherapeutic products and microbiome CDMO market size is estimated to hit around USD 1,838.56 million by 2035 from USD 106.79 million in 2026, at a CAGR of 37.38%.
September 2026
The LNP CDMO market reached USD 271.03 million in 2026, featuring leading LNP CDMO market companies such as Lonza Group, WuXi AppTec, Samsung Biologics.
September 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
September 2026
The global pharmaceutical analytical testing market size is expected to hit around USD 22.60 billion by 2035 from USD 10.76 billion in 2026 , with a CAGR of 8.62%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com